These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1091001

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary.
    Cooper EE, Michel AM.
    Adv Exp Med Biol; 1977; 82():191-4. PubMed ID: 920358
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Focus on fenofibrate.
    Brown WV.
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
    Glueck CJ, Fallat RW, Mellies M, Tsang RC.
    Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
    [Abstract] [Full Text] [Related]

  • 31. Effects of colestipol hydrochloride (U-26,597A) on serum and fecal lipids in dogs.
    Parkinson TM, Schneider JC, Phillips WA.
    Atherosclerosis; 1973 Jan; 17(2):167-79. PubMed ID: 4709118
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The acceptability of resin therapy to patients attending a hospital lipid clinic.
    Iversen SA, Davidson D, Davidson C.
    Br J Clin Pharmacol; 1995 Jul; 40(1):92-4. PubMed ID: 8527276
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
    Molcányiová A, Stancáková A, Javorský M, Tkác I.
    Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
    [Abstract] [Full Text] [Related]

  • 35. Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study.
    Ruoff G.
    J Am Geriatr Soc; 1978 Mar; 26(3):121-6. PubMed ID: 624819
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Long-term therapy of hypercholesteremia in diabetics with colestipol].
    Düntsch G.
    Fortschr Med; 1981 Jan 22; 99(3):73-5. PubMed ID: 6781999
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Current and future therapeutic approaches to hyperlipidemia.
    Farmer JA, Gotto AM.
    Adv Pharmacol; 1996 Jan 22; 35():79-114. PubMed ID: 8920205
    [No Abstract] [Full Text] [Related]

  • 40. Colesevelam hydrochloride.
    Steinmetz KL.
    Am J Health Syst Pharm; 2002 May 15; 59(10):932-9. PubMed ID: 12040732
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.